MAZE logo

Maze Therapeutics, Inc. (MAZE) Cash From Investing

Annual CFI:

-$1.15M-$706.00K(-160.09%)
December 31, 2024

Summary

  • As of today, MAZE annual cash from investing is -$1.15 million, with the most recent change of -$706.00 thousand (-160.09%) on December 31, 2024.
  • During the last 3 years, MAZE annual cash from investing has risen by +$2.02 million (+63.82%).
  • MAZE annual cash from investing is now -160.09% below its all-time high of -$441.00 thousand, reached on December 31, 2023.

Performance

1-Year Change

-160.09%

3-Year Change

+63.82%

5-Year Change

+63.82%

15-Year Change

+63.82%

MAZE Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

44.23%
MAZE annual cash from investing is higher than 44.23% of companies in Healthcare sector

Range

All-Time High

-$441.00K
MAZE annual cash from investing is currently -160.09% below its historical high of -$441.00 thousand

3-Year Low

-$3.17M
MAZE annual cash from investing is currently +63.82% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MAZE previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 5, 2026
MAZE next annual earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

Annual CFF

$92.85M
MAZE annual cash from financing is $92.85 million

Annual CFO

$75.95M
MAZE annual cash from operations is $75.95 million

Annual FCF

$74.81M
MAZE annual free cash flow is $74.81 million

Annual CAPEX

$1.15M
MAZE annual capital expenditures is $1.15 million

Quarterly CFI:

-$66.88M-$66.49M(-16918.58%)
September 30, 2025

Summary

  • As of today, MAZE quarterly cash from investing is -$66.88 million, with the most recent change of -$66.49 million (-16918.58%) on September 30, 2025.
  • MAZE quarterly cash from investing is now -196614.71% below its all-time high of -$34.00 thousand, reached on December 31, 2023.

Performance

3-Month Change

-16918.58%

1-Year Change

-

3-Year Change

-16333.17%

5-Year Change

-16333.17%

MAZE Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.59%
MAZE quarterly cash from investing is higher than 10.59% of companies in Healthcare sector

Range

All-Time High

-$34.00K
MAZE quarterly cash from investing is currently >-9900.00% below its historical high of -$34.00 thousand

3-Year Low

-$66.88M
MAZE quarterly cash from investing is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MAZE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
MAZE next earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

Quarterly CFF

$143.76M
MAZE quarterly cash from financing is $143.76 million

Quarterly CFO

-$24.64M
MAZE quarterly cash from operations is -$24.64 million

Quarterly FCF

-$24.71M
MAZE quarterly free cash flow is -$24.71 million

Quarterly CAPEX

$68.00K
MAZE quarterly capital expenditures is $68.00 thousand

TTM CFI:

-$68.18M-$66.88M(-5156.75%)
September 30, 2025

Summary

  • As of today, MAZE TTM cash from investing is -$68.18 million, with the most recent change of -$66.88 million (-5156.75%) on September 30, 2025.
  • MAZE TTM cash from investing is now -16651.84% below its all-time high of -$407.00 thousand, reached on September 1, 2023.

Performance

3-Month Change

-5156.75%

1-Year Change

-

3-Year Change

-16651.84%

5-Year Change

-16651.84%

MAZE TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

19.55%
MAZE TTM cash from investing is higher than 19.55% of companies in Healthcare sector

Range

All-Time High

-$407.00K
MAZE TTM cash from investing is currently >-9900.00% below its historical high of -$407.00 thousand

3-Year Low

-$68.18M
MAZE TTM cash from investing is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MAZE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
MAZE next earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

TTM CFF

$342.01M
MAZE TTM cash from financing is $342.01 million

TTM CFO

-$106.66M
MAZE TTM cash from operations is -$106.66 million

TTM FCF

-$108.03M
MAZE TTM free cash flow is -$108.03 million

TTM CAPEX

$1.36M
MAZE TTM capital expenditures is $1.36 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MAZE Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-160.1%--
3Y3 Years+63.8%-10000.0%-10000.0%
5Y5 Years+63.8%-10000.0%-10000.0%

MAZE Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-160.1%+63.8%>-9999.0%at low>-9999.0%at low
5Y5-Year-160.1%+63.8%>-9999.0%at low>-9999.0%at low
All-TimeAll-Time-160.1%+63.8%>-9999.0%at low>-9999.0%at low

MAZE Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$66.88M(>-9900.0%)
-$68.18M(-5156.7%)
Jun 2025
-
-$393.00K(-31.4%)
-$1.30M(-43.5%)
Mar 2025
-
-$299.00K(+50.6%)
-$904.00K(-2.3%)
Dec 2024
-$1.15M
-$605.00K(-116.8%)
-$884.00K(-22.8%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$279.00K(-720.6%)
-$720.00K(-63.3%)
Dec 2023
-$441.00K(+86.1%)
-$34.00K(+91.6%)
-$441.00K(-8.4%)
Sep 2023
-
-$407.00K
-$407.00K
Dec 2022
-$3.17M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Maze Therapeutics, Inc.?

What is Maze Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of MAZE is -$1.15M

What is the all-time high annual cash from investing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual cash from investing is -$441.00K

What is Maze Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, MAZE annual cash from investing has changed by -$706.00K (-160.09%)

What is Maze Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of MAZE is -$66.88M

What is the all-time high quarterly cash from investing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly cash from investing is -$34.00K

What is Maze Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of MAZE is -$68.18M

What is the all-time high TTM cash from investing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM cash from investing is -$407.00K
On this page